22.3: Molecules Derived from Amino Acids

Search Fundamentals of Biochemistry

Learning Goals (ChatGPT o3-mini)

1. Describe Diverse Metabolic Fates of Amino Acids:

   • Explain how amino acids serve as building blocks for proteins and also feed into central metabolic pathways (e.g., TCA cycle and gluconeogenesis) by conversion into intermediates like oxaloacetate, α‑ketoglutarate, or acetyl‑CoA.
   • Discuss how branched‐chain amino acids contribute to both energy production and lipid synthesis.

2. Integrate Amino Acid Catabolism with Energy Metabolism:

   • Analyze how amino acid catabolism provides substrates for energy production in different nutritional states (fed, fasting, or in metabolic diseases such as diabetes).
   • Relate the concept of anaplerosis (e.g., through glutamine conversion to α‑ketoglutarate) to cancer cell metabolism and the Warburg effect.

3. Explain Polyamine Biosynthesis and Function:

   • Outline the pathway for polyamine synthesis from arginine and S-adenosylmethionine (SAM) and identify the main biological polyamines (putrescine, spermidine, spermine, and cadaverine).
   • Discuss the significance of polyamines in regulating nucleic acid structure, gene transcription, and cellular proliferation (including their role in tumor growth).

4. Describe Glutathione Synthesis and Its Role in Redox Balance:

   • Summarize the enzymatic steps in the synthesis of glutathione (GSH) from glutamate, cysteine, and glycine.
   • Explain how glutathione, in conjunction with NADPH (derived from pathways like the pentose phosphate pathway and the serine–glycine one‑carbon cycle), maintains cellular redox homeostasis and defends against oxidative stress.

5. Outline the Heme Biosynthetic Pathway:

   • Describe the key steps in heme biosynthesis, including the rate‑limiting reaction catalyzed by 5‑aminolevulinic acid synthase (ALA‑S) and the subsequent conversion of ALA to protoporphyrin IX, and finally insertion of iron to form heme.
   • Compare the C4 (used by mammals, fungi, and some bacteria) and C5 pathways (used by plants, archaea, and most bacteria) for ALA synthesis.

6. Understand the Synthesis of Amino Acid-Derived Neurotransmitters:

   • Identify which amino acids serve as neurotransmitters (e.g., glutamate, aspartate, glycine) and those that are precursors to amine neurotransmitters (e.g., tyrosine to catecholamines, tryptophan to serotonin).
   • Explain how compartmentalization of amino acids in neurons supports both their metabolic functions and their role in synaptic transmission.

7. Explain Regulation and Mechanism of Catecholamine Synthesis:

   • Describe the conversion of tyrosine to dihydroxyphenylalanine (DOPA) by tyrosine hydroxylase and outline subsequent steps leading to dopamine, norepinephrine, and epinephrine synthesis.
   • Discuss the feedback inhibition of tyrosine hydroxylase by dopamine and the regulatory role of serine 40 phosphorylation in modulating its activity.

8. Integrate Amino Acid Metabolism with Broader Cellular Processes:

   • Explain how the breakdown and conversion of amino acids not only provide energy but also supply precursors for the biosynthesis of nucleotides (to be discussed in a later chapter) and other critical metabolites such as polyamines, heme, and neurotransmitters.
   • Evaluate the importance of balancing amino acid utilization for energy versus biosynthesis in both normal physiology and in pathological conditions like cancer.

These learning goals are intended to help students build a systems-level understanding of how amino acids are not only the building blocks of proteins but also pivotal molecules that integrate and regulate energy metabolism, redox balance, and cell signaling.

Introduction

Once made or ingested, amino acids have many metabolic fates. Of course, they are used for the synthesis of proteins. Aspartate and glutamate (and indirectly glutamine) can be converted to oxaloacetate and α-ketoglutarate, respectively, and used in the citric acid cycle for energy production. They can also be used for gluconeogenesis, utilizing both mitochondrial and cytoplasmic enzymes. Branched-chain amino acids can be converted to acetyl-CoA and used in energy production or fat synthesis. A review summary of the use of amino acids in energy and biosynthetic metabolic pathways is shown in Figure \(\PageIndex{1}\).

Figure \(\PageIndex{1}\): Review summary of the use of amino acid in energy and biosynthetic metabolic pathways. Lieu, E.L., Nguyen, T., Rhyne, S., et al. Amino acids in cancer. Exp Mol Med 52, 15–30 (2020). https://doi.org/10.1038/s12276-020-0375-3. Creative Commons Attribution 4.0 International License, http://creativecommons.org/licenses/by/4.0/.

Amino acids are shown in green, and other metabolites are in red. Orange represents transporters. Yellow boxes signify enzymes. Lesser known abbreviations for species include SHMT1 serine hydroxymethyltransferase, cytosolic, BCAT branched-chain amino acid transaminase, mitochondrial, BCAA branched-chain amino acid (valine, leucine, isoleucine), BCKA branched-chain ketoacid, GOT1 aspartate transaminase, cytosolic (AST), GLS glutaminase, GS glutamine synthetase (cytosolic and mitochondrial), ASNS asparagine synthetase, PRODH pyrroline-5-carboxylate dehydrogenase, PYCR pyrroline-5-carboxylate reductase, P5C pyrroline-5-carboxylate, GSH glutathione, PRPP phosphoribosyl pyrophosphate, LAT1 large-neutral amino acid transporter 1, SLC25A44 solute carrier family 25 member 44, GLUT glucose transporter,

Cancer cells have an increased need for fuels and biosynthetic intermediates. Both can be derived from amino acids, as described previously. Glutamine is a key amino acid, especially when glucose is depleted, as it is converted into α-ketoglutarate (α-KG) and subsequently into oxaloacetate (OAA), which powers the TCA cycle by increasing the levels of fumarate, malate, and citrate. Hence, it is both anaplerotic and a source of fuel.

Similar increases in citrate occur in hypoxia. Aerobic glycolysis, also known as the Warburg effect, occurs in cancer cells, which exhibit enhanced glucose uptake and conversion to lactate even in the presence of oxygen. This process can occur so rapidly that the amount of ATP produced in cancer cells through aerobic glycolysis can be comparable to that produced through oxidative metabolism in the mitochondria, despite being far less efficient. More information on cancer cell metabolism is found in Chapter 23.

In this chapter, we will discuss the conversion of amino acids to other molecules that are not directly involved in these metabolic pathways. We will focus on their use for the synthesis of polyamines, heme, and neurotransmitters. We will not discuss the detailed mechanisms or structures of the proteins and enzymes involved in these pathways. In the next chapter section (22.4), we will present amino acids as substrates in synthesizing pyrimidine and purine bases, which are essential for nucleotides and nucleic acids.

Polyamine synthesis

If a non-quaternary amine has a single positive charge when protonated, a polyamine can have multiple positive charges. Hence, they would be expected to bind to almost any negatively charged biomolecule, especially those with multiple negative charges. These include polyanions such as RNA and DNA, as well as proteins and lipid bilayers. They would then be able to regulate many features of cell life, including DNA replication and transcription, RNA translation, and a multitude of binding interactions. The question arises of whether these interactions are nonspecific or specific, and in which case they can be considered key regulators of cellular activity. Polyamine response elements have been found that regulate the transcription of genes, including c-Myc and c-Jun. Polyamines have been shown to affect tumor growth and aggressiveness.

The primary biological polyamines include putrescine, spermine, and spermidine. Another is cadaverine. Given their names, you can surmise that they smell horrible. The synthesis of three polyamines from arginine and SAM is shown in Figure \(\PageIndex{2}\).

Figure \(\PageIndex{2}\): Polyamine synthesis form arginine and SAM

Glutathione synthesis and redox balance

Glutathione, γ-glutamylcysteinylglycine (GSH), is a chief regulator of the oxidation state of a cell. As a disulfide bond can be cleaved and hence reduced by the excess concentration of a thiol (sulfhydryl) like β-mercaptoethanol (which gets oxidized in the process), the free thiol on glutathione can act as a reducing agent in the cell. Reactive oxygen species (ROS) production in normal cells, but especially in tumor cells, which have increased oxygen demand and utilization, is countered by generating an antioxidant defense state. This is partially characterized by increased levels of reductants such as NADPH, especially glutathione. It can react with H₂O₂ through the enzyme GSH peroxidase to form water and the oxidized disulfide form of GSH, GSSG. The GSSG is reduced back to GSH by glutathione reductase (GR) and NADPH. Figure \(\PageIndex{3}\) shows glutathione synthesis from glutamate, cysteine, and glycine.

Figure \(\PageIndex{3}\): Synthesis of glutathione

NADPH is generated in the cell by the phosphopentose pathway metabolism of glucose and malic enzyme. It can also be generated from the Ser-Glycine One Carbon Cycle (SGOT), which we saw in Chapter 18.4 and is shown again in Figure \(\PageIndex{4}\). Under appropriate conditions, this cycle can produce NADPH.

Figure \(\PageIndex{4}\): The Ser-Gly One Carbon (SGOC) Cycle

HIF1α upregulates Serinehydroxymethyltransferase (SHMT) 2 and helps maintain the NADPH/NADP⁺ ratio. Given the connection between the SGOC and the methionine cycle through folate, a decrease in serine concentration leads to a decrease in GSH.

Heme Biosynthesis

This section is derived from Aminat S. Ogun; Neena V. Joy; Menogh Valentine. https://www.ncbi.nlm.nih.gov/books/NBK537329/. Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/)

Heme is a macrocyclic tetrapyrrole ring structure containing two nonpolar vinyl groups on one edge and two charged propionates on the other. It is extensively conjugated with 26 π electrons (4n+2 = 4(6)+2), so it is aromatic. The molecule without Fe²⁺ is called protoporphyrin IX. With a centrally coordinated Fe²⁺, it is called heme. Both structures are shown in Figure \(\PageIndex{5}\).

Figure \(\PageIndex{5}\): Structure of protoporphyrin IX and heme

It is found in oxygen-binding proteins and as substrates and cofactors for enzymes involved in electron transport. It is synthesized in the bone marrow and liver. Alternative forms of heme include heme b (in hemoglobin), heme a (cytochrome a), and heme c (cytochrome c).

Its synthesis, as expected given its macrocyclic structure, is complicated. The key enzyme in the pathway for regulation is 5'-Aminolevulinic acid synthase (ALA-S). Liver and bone express ALAS2, while ALAS1 is expressed in all tissues. The synthesis process begins in the mitochondria and concludes in the cytosol. Figure \(\PageIndex{6}\) shows the overall pathway for heme synthesis.

Figure \(\PageIndex{6}\): Heme biosynthetic pathway. Wikimedia Commons file: Heme-Synthesis-Chemical-Details-Mirror.svg

5'-Aminolevulinic acid synthase (ALA-S), a pyridoxal phosphate-dependent enzyme, catalyzes the rate-limiting step in heme synthesis in the liver and erythroid cells. It is highly regulated. There are two forms of ALA Synthase, ALAS1 and ALAS2. All cells express ALAS1, while only the liver and bone marrow express ALAS2. The gene for ALAS2 is on the X chromosome. After the synthesis of ALA in the mitochondria, it moves into the cytoplasm for the remaining steps.

Figure \(\PageIndex{7}\) shows a likely mechanism for the first committed step, the production of ALA. This enzyme synthesizes all tetrapyrroles, including heme, chlorophyll, and cobalamin.

Figure \(\PageIndex{7}\): Mechanism for 5'-Aminolevulinic acid synthesis by ALAS (Wikipedia. https://en.Wikipedia.org/wiki/Aminol..._acid_synthase)

The pathway shown in Figure 6 above is known as the C4 pathway and is found in mammals, fungi, and certain types of bacteria, including purple nonsulfur bacteria. A C5 pathway is found in most bacteria, all archaea, and plants. The biosynthetic pathway for heme synthesis in E. Coli is shown in Figure \(\PageIndex{8}\).

Figure \(\PageIndex{8}\): Heme pathway in E. coli. Zhang, J., Kang, Z., Chen, J. et al. Optimization of the heme biosynthesis pathway for the production of 5-aminolevulinic acid in Escherichia coli. Sci Rep 5, 8584 (2015). https://doi.org/10.1038/srep08584. Creative Commons Attribution 4.0 International License. http://creativecommons.org/licenses/by/4.0/

The pathway is divided into three modules: Module I, Module II, and Module III, as shown in the dotted box. The green and red arrows represent the positive and negative enzymes for ALA accumulation, respectively. Dotted red arrows represent the feedback inhibition. α-KG: α-ketoglutarate, GSA: glutamate-1-semialdehyde, ALA: 5-aminolevulinic acid, PBG: porphobilinogen, HMB: hydroxymethylbilane, GltX: glutamyl-tRNA synthetase, HemA: glutamyl-tRNA reductase, HemL: glutamate-1-semialdehyde aminotransferase, HemB: 5-aminolevulinic acid dehydratase, HemC: porphobilinogen deaminase, HemD: uroporphyrinogen III synthase, HemE: uroporphyrinogen decarboxylase, HemF: coproporphyrinogen III oxidase, HemG: protoporphyrin oxidase, HemH: ferrochelatase.

Heme increases globin protein synthesis in immature red blood cells (reticulocytes). The hormone erythropoietin increases heme synthesis. In the liver, heme is part of cytochrome P450s. An increased concentration of drugs causes an increase in ALAS1, which in turn produces the cytochrome P450s to metabolize them. Also, low heme concentration increases ALAS1 transcription. Mutations in ALAS2 can lead to X-linked sideroblastic anemia from decreased heme production, even as Fe²⁺ continues to enter the cell.

Yeast ALAS is a homodimer with PLP covalently attached through a Schiff base link to lysine 337 of just one of the monomers. The structures of a noncovalent complex of PLP with ALAS (pdb 5TXR) and the covalently bound one (5TXT) show large changes in the protein conformation. PLP, when covalently attached, reorders the active. A C-terminal extension not found in bacteria wraps around the dimer, binds near the active site, and is important for activity. Mutations in the tail can result in human diseases.

Figure \(\PageIndex{9}\) shows an interactive iCn3D model of the 5-aminolevulinic acid synthase with covalently attached PLP (5TXT).

Figure \(\PageIndex{9}\): 5-aminolevulinic acid synthase with covalently attached PLP (5TXT). (Copyright; author via source). Click the image for a popup or use this external link: https://structure.ncbi.nlm.nih.gov/icn3d/share.html?fTBbWuS3HPTP8uRm9

Lysine 337 (spacefill, CPK colors, labeled) is shown in the A chain (magenta, no bound PLP). Lys 337 in the B chain (cyan) is covalently linked to PLP. The side chain of lysine 337 covalently attached to PLP is shown in spacefill, CPK colors, and labeled. The C-terminal extension (493–548) is a red backbone chain. The very distal end of the extension is disordered and missing in the B chain (cyan).

Figure \(\PageIndex{10}\) shows an interactive iCn3D model of aligned 5-aminolevulinic acid synthase with free PLP (not covalently attached, 5TXR) and with covalently attached PLP (5TXT ).

 Figure \(\PageIndex{11}\): Alignment of 5-aminolevulinic acid synthase with free PLP (5TXR) and with covalently attached PLP (5TXT ). (Copyright; author via source). Click the image for a popup or use this external link: https://structure.ncbi.nlm.nih.gov/i...aqN4Qpi2pSLkD7

The 5TXT structure contains two molecules of a stabilizing molecule, shown in stick form, which can be ignored. The A chain is magenta, and the B chain is cyan. Press "a" to toggle back and forth between the structures. The C-terminal extension is missing from the figure.

Figure \(\PageIndex{11}\) shows another view of heme synthesis, highlighting the roles of mitochondrial and cytoplasmic enzymes.

Figure \(\PageIndex{11}\): Mitochondrial and cytosolic contributions to heme synthesis. https://commons.wikimedia.org/wiki/F..._synthesis.png

Neurotransmitters

The section below is modified from Manorama Patri. Synaptic Transmission and Amino Acid Neurotransmitters. DOI: 10.5772/intechopen.82121. https://www.intechopen.com/books/neu...rotransmitters. Creative Commons Attribution 3.0 License,

Three major categories of amino acids and their derivatives act as neurotransmitters:

1. Amino acids: The neurotransmitters of this group are involved in fast synaptic transmission and are inhibitory and excitatory in action (primarily glutamic acid, GABA, aspartic acid, and glycine).
2. Amines: Amines are modified amino acids such as biogenic amines, e.g., catecholamines. The neurotransmitters of this group are involved in slow synaptic transmission and exhibit both inhibitory and excitatory actions (noradrenaline, adrenaline, dopamine, serotonin, and histamine).
3. Others: The ones that do not fit in any of these categories (acetylcholine and nitric oxide). Amino acids are among the most abundant of all neurotransmitters present within the central nervous system (CNS).

Amino acid transmitters provide the majority of excitatory and inhibitory neurotransmission in the nervous system. Amino acids used for synaptic transmission are compartmentalized (e.g., glutamate, compartmentalized from metabolic glutamate used for protein synthesis by packaging the transmitter into synaptic vesicles for subsequent Ca²⁺-dependent release). Amino acid neurotransmitters are all products of intermediary metabolism except GABA. Unlike all the other amino acid neurotransmitters, GABA is not used in protein synthesis and is produced by an enzyme (glutamic acid decarboxylase; GAD) uniquely located in neurons.

Here is some more specific information:

• Glutamate: Glutamate is used at most fast excitatory synapses in the brain and spinal cord. Glutamate binds to glutamate receptors, of which there are many subtypes based on other molecules (some amino acid derivatives) that can bind to them. These other molecules include N-methyl-D-aspartate (NMDA), α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA), kainate, and quisqualate.
• Aspartate: Aspartate is the most abundant excitatory neurotransmitter in the CNS. Like glycine, aspartate is primarily localized to the ventral spinal cord. Note that the two major excitatory neurotransmitters both have carboxylic acid side chains.
• Gamma-aminobutyric acid (GABA): GABA, which is not one of the canonical amino acids used in protein biosynthesis, is the most ubiquitous inhibitory neurotransmitter in the brain.
• Glycine: these receptors are ligand-gated ion channels that increase Cl⁻ influx and hence are generally inhibitory. Hydroxymethyl transferase converts the amino acid serine to glycine. Glycine has been found to play a role in the functional modulation of NMDA receptors.

The pathways for synthesizing amino acid-derived bioactive amines and neurotransmitters are shown in Figure \(\PageIndex{12}\).

Figure \(\PageIndex{12}\): Pathways for the synthesis of amino acid-derived bioactive amines and neurotransmitters

Note the structural similarity of the psychotropic and hallucinogenic drug LSD to serotonin (5HT), amphetamines to norepinephrine and epinephrine, and melatonin (a substance some take as a sleeping aid and which is formed in the dark at night in the brain. The name catecholamines derives from the common name of the 1,2-dihydroxybenzene group (catechol).

Tyrosine hydroxylase (TH) catalyzes the first and rate-limiting step in catecholamine synthesis. Although it lacks heme, it contains Fe2+ and tetrahydrobiopterin as cofactors used in the synthesis of dihydroxyphenylalanine (DOPA). Tyrosine hydroxylase is also the rate-limiting enzyme for the synthesis of all three neurotransmitters.

Catecholamines, including dopamine, a downstream product, inhibit the enzyme, which is activated by phosphorylation on serine 40. The structures of TH in the absence of dopamine and the pSer40 state are known. The protein is a tetramer, consisting of a regulatory domain (a dimer) and a catalytic domain (also a dimer), separated by 15 Å.

The mammalian TH is a member of the aromatic amino acid hydroxylases (AAAHs), mainly found as homotetramers. Each subunit has three domains:

• The N-terminal regulatory domain (RD) consists of an unstructured, variable-length section followed by an ACT (aspartate kinase-chorismate mutase-TyrA) domain. The N-terminal tail contains serine 40, which, on phosphorylation, relieves the inhibition when dopamine is bound to the catalytic domain.
• a central catalytic domain (CD) that binds Fe²⁺, aromatic amino acid substrates, and the tetrahydrobiopterin cofactor
• C-terminal oligomerization domain (OD) leads to the formation of dimers and tetramers.

Figure \(\PageIndex{13}\) illustrates a potential model that depicts dopamine (DA)-mediated feedback inhibition and its regulation by serine 40 phosphorylation, resulting from the interaction between the N-terminal tail of the regulatory domain (RD) and the catalytic domain. All forms containing bound dopamine (yellow star) are inactive.

Figure \(\PageIndex{13}\): Cartoon model of DA-mediated feedback inhibition and its regulation by S40 phosphorylation. Bueno-Carrasco, M.T., Cuéllar, J., Flydal, M.I. et al. Structural mechanism for tyrosine hydroxylase inhibition by dopamine and reactivation by Ser40 phosphorylation. Nat Commun 13, 74 (2022). https://doi.org/10.1038/s41467-021-27657-y. Creative Commons Attribution 4.0 International License. http://creativecommons.org/licenses/by/4.0/.

In the active, apo, and non-phospho states, the 39−58 α-helix of the N-terminal regulatory domain of TH is detached from the main structure (I, apo-TH). The feedback inhibitor DA binds to the TH active site, most likely in the open conformation (I′, TH(DA)). DA-binding favors the interaction of the N-terminal α-helix with the same binding site, which blocks DA exit and contributes to the high-affinity binding and strong inhibition of TH activity (II, TH(DA)). Protein Kinase (PK) phosphorylation of S40 in TH(DA), leads to state III (THS40p(DA)), prompting the detachment of the α-helix from the TH active site (IV′), which opens up for DA-dissociation and activation (IV, THS40p). PKs and protein phosphatases (PPs) control the transition between THS40p and unphosphorylated TH for both DA-bound (I′ ↔ IV′ and II ↔ III) and apo-TH (I ↔ IV). States I′ and III are expected to be only transiently populated during DA binding, as states II and IV will be more stable. Hence, states I′ and III are faded. S40 is also expected to be less accessible in state II than in state I, as indicated by the stippled lines for phosphorylation of TH in state II. The case for dephosphorylation is unknown, but it could be expected that state III is a poorer substrate for PP than the open states IV′ and IV. The dephosphorylation reaction III → II is therefore also stippled. The states where we provide structural details in this work (I, II, and IV) are marked with circles.

Figure \(\PageIndex{14}\) shows a model of the TH active site changes on phosphorylation of serine 40 using structural and molecular dynamics approaches that led to the cartoon model above.

Figure \(\PageIndex{14}\): Modeling of the TH active site.

Panel (a) shows models demonstrating the effect of serine 40 phosphorylation on the interaction of the N-terminal α-helix with bound dopamine (DA). Representative conformations from the last 50 ns of a 500 ns MD simulation for TH(DA) (grey ribbon) and pS40-TH(DA) (light blue ribbon) are shown. The resulting structures show a slight shift of the N-terminal α-helix upon phosphorylation, most probably due to electrostatic repulsion between the phosphate and E325, E375, and D424.

Panel (b) shows a detailed view of the atomic model of the TH(DA) active site. (left) The N-terminal α-helix (orange) establishes connections with the adjacent helix D360-E375 and with residues of the 290–297 and 420–429 loops (blue, right).

Pane (c) shows a cartoon depicting the interactions between N-terminal α-helix residues that enter the active site and residues of adjacent regions.

Figure \(\PageIndex{15\) below shows an interactive iCn3D model of the full-length tyrosine hydroxylase in complex with dopamine (residues 40-497) in which the regulatory domain (residues 40-165) has been included only with the backbone atoms (6zvp)

Figure \(\PageIndex{15}\): Tyrosine hydroxylase dopamine complex (6zvp). (Copyright; author via source). Click the image for a popup or use this external link: https://structure.ncbi.nlm.nih.gov/i...hu6vJn22eDkWw7

Finally, Figure \(\PageIndex{16}\) shows an interactive iCn3D model of the active site of tyrosine hydroxylase in complex with dopamine (6zvp)

Figure \(\PageIndex{16}\): Active site of tyrosine hydroxylase dopamine complex (6zvp). (Copyright; author via source). Click the image for a popup or use this external link: https://structure.ncbi.nlm.nih.gov/icn3d/share.html?sx5obQnzojmKXuLS9

The side chains binding the active site Fe²⁺ and the interaction of Fe²⁺ with dopamine (LDP) are shown in sticks and labeled. The oxygen of serine 40 is shown as a red sphere. Dopamine is the molecule containing 1,2-dihydroxybenzene.

Figure \(\PageIndex{17}\) shows a final summary presentation of the conversion of phenylalanine, tyrosine, and tryptophan to neurotransmitters.

Figure \(\PageIndex{17}\): Comparison of monoamine synthesis pathways. Adapted from Hochman, Shawn. (2015). Neural Regeneration Research. 10. 10.4103/1673-5374.169625. Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International

Summary

Amino acids, while famously known as the building blocks of proteins, play several pivotal roles in cellular metabolism. This chapter broadens the perspective by highlighting how amino acids serve as substrates for energy production, biosynthesis of vital small molecules, and regulation of cellular processes.

Energy Metabolism and Anaplerosis:
Amino acids can be converted into key intermediates of central metabolic pathways. For example, aspartate and glutamate (via glutamine) are transformed into oxaloacetate and α‑ketoglutarate, respectively, which enter the tricarboxylic acid (TCA) cycle. Branched‑chain amino acids (valine, leucine, and isoleucine) are metabolized to acetyl‑CoA, thereby contributing to both energy production and lipid biosynthesis. The chapter also discusses how under different nutritional states—such as the fed state, fasting, or in metabolic diseases like diabetes—amino acids serve as critical fuel sources when carbohydrates and lipids are less available or in excess.

Biosynthesis of Specialized Metabolites:
Beyond energy, amino acids are precursors for several key biomolecules:

• Polyamines: Derived from arginine and S‑adenosylmethionine (SAM), polyamines such as putrescine, spermidine, and spermine play crucial roles in stabilizing nucleic acids, regulating gene expression, and modulating cell proliferation. These polycations interact with negatively charged molecules (e.g., DNA, RNA) and are linked to the control of cell growth, with implications in cancer biology.
• Glutathione and Redox Homeostasis: The tripeptide glutathione (γ‑glutamylcysteinylglycine) is synthesized from glutamate, cysteine, and glycine. It is a central antioxidant that maintains the cellular redox state by neutralizing reactive oxygen species (ROS). Glutathione functions in concert with NADPH, which is generated via the pentose phosphate pathway and the serine–glycine one‑carbon cycle, to protect cells from oxidative stress.
• Heme Biosynthesis: Heme is a tetrapyrrole cofactor essential for oxygen transport and electron transfer. Its biosynthesis begins with the formation of 5‑aminolevulinic acid (ALA) by ALA synthase—a rate‑limiting, pyridoxal phosphate‑dependent reaction in the mitochondria—and proceeds through both mitochondrial and cytosolic steps to yield protoporphyrin IX. Subsequent insertion of iron produces heme, with specific pathways differing between the C4 (mammals and fungi) and C5 (plants, archaea, most bacteria) routes for ALA synthesis.

Amino Acids as Neurotransmitter Precursors:
The chapter also covers how amino acids contribute to the nervous system:

• Direct Neurotransmission: Amino acids like glutamate, aspartate, glycine, and GABA serve directly as neurotransmitters in the central nervous system, mediating fast synaptic transmission.
• Precursor Roles: Other amino acids, particularly tyrosine and tryptophan, are precursors to biogenic amines (e.g., dopamine, norepinephrine, serotonin). The synthesis of catecholamines begins with tyrosine hydroxylase, a key regulatory enzyme whose activity is finely tuned by feedback inhibition (via dopamine) and by phosphorylation (notably at serine 40).

Integration and Regulation:
This chapter emphasizes that the fates of amino acids are tightly interconnected with broader metabolic networks. The balance between their use in energy production versus biosynthesis of compounds like polyamines, glutathione, heme, and neurotransmitters is critical for maintaining cellular homeostasis. The dynamic regulation of these pathways is essential not only under normal physiological conditions but also in disease states, such as cancer, where metabolic reprogramming occurs.

In summary, this chapter provides an integrated view of how amino acids are metabolically versatile, serving as both fundamental components for building macromolecules and as substrates for key biosynthetic and energy-producing pathways that underpin vital cellular functions.

---